Literature DB >> 9245831

Iron acquisition from transferrin and lactoferrin by Pseudomonas aeruginosa pyoverdin.

Byeong C Jeong1, Chris Hawes2, Karen M Bonthrone1, Lynne E Macaskie1.   

Abstract

Growth of Pseudomonas aeruginosa ATCC 15692 was promoted when the strain was cultured in an iron-depleted succinate medium, supplemented with transferrin at 30%, 60% and 100% and lactoferrin at 60% and 100% iron-saturation. No significant differences between cell growth and pyoverdin production were observed when transferrin iron saturation was increased from 30% to 100%; however, cell growth and pyoverdin production were strongly dependent on lactoferrin iron saturation. Lower lactoferrin iron saturation (< 30%) resulted in more pyoverdin production and reduced cell growth. Incubation of pyoverdin (1.0 microM) with 10.0 microM transferrin (30%, 60% and 100% iron-saturated) or lactoferrin (60% and 100% iron-saturated) led to quenching of pyoverdin fluorescence. Also, 24 h incubation of pyoverdin (20.0 microM) with these two proteins (20.0 microM, 30%, 60% and 100% iron-saturated transferrin and 60% and 100% iron-saturated lactoferrin) at 25 degrees C resulted in increased absorbance at 460 nm. Both the fluorescence quenching and absorbance increases were iron-saturation-dependent. Taken together, these results support the conclusion that at physiological pH, P. aeruginosa pyoverdin can acquire from partially iron-saturated transferrin or lactoferrin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245831     DOI: 10.1099/00221287-143-7-2509

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  20 in total

Review 1.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

2.  The human innate immune protein calprotectin induces iron starvation responses in Pseudomonas aeruginosa.

Authors:  Emily M Zygiel; Cassandra E Nelson; Luke K Brewer; Amanda G Oglesby-Sherrouse; Elizabeth M Nolan
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

3.  Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection.

Authors:  Fabrizia Minandri; Francesco Imperi; Emanuela Frangipani; Carlo Bonchi; Daniela Visaggio; Marcella Facchini; Paolo Pasquali; Alessandra Bragonzi; Paolo Visca
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

Review 4.  Connecting iron acquisition and biofilm formation in the ESKAPE pathogens as a strategy for combatting antibiotic resistance.

Authors:  Savannah J Post; Justin A Shapiro; William M Wuest
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

Review 5.  Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa.

Authors:  Donghoon Kang; Natalia V Kirienko
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

6.  Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice.

Authors:  H Takase; H Nitanai; K Hoshino; T Otani
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Roles of ompA of Citrobacter werkmanii in bacterial growth, biocide resistance, biofilm formation and swimming motility.

Authors:  Gang Zhou; Ying-Si Wang; Hong Peng; Su-Juan Li; Ting-Li Sun; Peng-Fei Shen; Xiao-Bao Xie; Qing-Shan Shi
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-25       Impact factor: 4.813

Review 8.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

Authors:  Ruxana T Sadikot; Timothy S Blackwell; John W Christman; Alice S Prince
Journal:  Am J Respir Crit Care Med       Date:  2005-02-01       Impact factor: 21.405

Review 9.  Thermal control of virulence factors in bacteria: a hot topic.

Authors:  Oliver Lam; Jun Wheeler; Christoph M Tang
Journal:  Virulence       Date:  2014       Impact factor: 5.882

Review 10.  Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic.

Authors:  M C Ammons; V Copié
Journal:  Biofouling       Date:  2013       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.